The  Geriatrics Forum

Fall 1999, Page 3

Focus - Continued from Page 1
these methods, they have shown that dopamine metabolism is increased in striatum and other brain nuclei during motor activity.

As a direct result of their demonstration that dopamine release is dynamically regulated during movement, Clinical Pharmacology faculty embarked on studies of neurotransplantation in rats, monkeys, and

humans to develop transplantation as a treatment for Parkinson's disease. In 1988, with neurosurgical colleague Robert Breeze, M.D., they performed the first transplant of human fetal dopamine cells into a Parkinson patient in the United States. That patient, now eleven years post transplant, showed improvement in his Parkinson's disease.

Using these transplant methods, Dr. Freed and his colleagues have conducted a double-blind, placebo-controlled surgical trial of fetal dopamine cell transplants. When subdivided by age, growth of transplant by F-dopa PET scan was the same in patients older and younger than age 60; however, only the group under age 60 showed clinical benefit. They concluded that cultured human fetal dopamine cell transplants survive and improve signs of advanced Parkinson's disease in younger patients even without immunosuppression.


Dr. Freed and his colleagues
have conducted a double-
blind, placebo-controlled
surgical trial of fetal
dopamine cell transplants.


From in vitro and in vivo studies, Clinical Pharmacology researchers have found that programmed cell death, or apoptosis, is the primary problem limiting dopamine cell survival after transplant. They have shown that growth factors such as bFGF, IGF-1 and GDNF can reduce the apoptopic rate. They are now developing genetically modified cells capable of synthesizing and storing dopamine as an alternative to the use of fetal brain cells.

They plan to continue this spectrum of research in rodents, monkeys and humans with the goal of developing a transplant cure for Parkinson's disease.



v

Funding Opportunities in Aging

Title:

Glenn Foundation/AFAR Scholarships for Research in the Biology of Aging

Agencies:

Glenn Foundation; American Federation for Aging Research and Digestive and Kidney Disease

Deadline:

February 25, 2000

Web site:

www.afar.org/glenngrnt.html


Title:

AFAR Research Grants

Agencies:

American Federation for Aging Research

Deadline:

December 15, 1999

Web site:

www.afar.org/afar99.html


Title:

AFAR/Pfizer Research Grants in Cardiovascular Diseases and Aging

Agencies:

American Federation for Aging Research; Pfizer, Inc.

Deadline:

December 15, 1999

Web site:

www.usalert.com/htdoc/usoa/fnd/any/any/proc/any/afar10029801.htm


Title:

Planning Grants for Biomedical Epidemiologic and Intervention Studies

Agencies:

National Institute on Aging; National Institute of Environment Health Sciences

PA Number:

PA-99-145

Web site:

www.usalert.com/htdoc/usoa/nih/nia/any/proc/any/08209912.htm


Title:

General Grants Program - Retirement Research Foundation

Agencies:

Retirement Research Foundation

Deadline:

February 1, 2000

Web site:

www.usalert.com/htdoc/usoa/fnd/any/any/proc/any/rrfo04299801.htm


Title:

Longitudinal Genetic Epidemiologic Studies on Aging

Agencies:

National Institute on Aging; National Institute of Environmental Health Sciences

Deadline:

January 12, 2000

RFA:

AG-99-007

Web site:

www.usalert.com/htdoc/usoa/nih/nia/any/proc/any/05079905.htm


Title:

Aging Women and Breast Cancer

Agencies:

National Institute on Aging; National Cancer Institute; National Institute of Nursing Research

PA Number:

PA-00-001

Web site:

www.usalert.com/htdoc/fed/nih/gen/any/proc/any/10089904.htm


Title:

John A. Hartford/AFAR Academic Geriatrics Fellowship Program

Agencies:

John A. Hartford Foundation; American Federation for Aging Research

Deadline:

February 18, 2000

Web site:

www.afar.org/fellows.html


Title:

John A. Hartford/AFAR Medical Student Geriatric Scholars Program

Agencies:

John A. Hartford Foundation; American Federation for Aging Research

Deadline:

February 7, 2000

Web site:

www.afar.org/medstu.html


Title:

Merck/AFAR Research Scholarships in Geriatric Pharmacology for Medical and Pharmacy Students

Agencies:

Merck Company Foundation; American Federation for Aging Research

Deadline:

January 21, 2000

Web site:

www.afar.org/merckstu.html

-1-   -2-   -3-   -4-
Return to Center of Excellence Homepage